Exercises and Performance Anxiety Among Young Instrumentalists.

June 5, 2023 updated by: Anna Cygańska

The Effect of an Exercise Program Designed for Young Instrumentalists (Musicians) on Music Performance Anxiety

The purpose of this study is to assess the impact of an original exercise program intended for students of the University of Music on dealing with stage fright and its psychophysical symptoms.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The study group covers students of a music university who play various musical instruments. Participants will be divided into the experimental and control groups. The study duration is scheduled to be 6 weeks. The control group will not have any intervention. The experimental group will undertake 45 mins exercise classes twice a week. Each exercise session will consist of an initial part (warm-up), a main part with exercises designed to strengthen the postural muscles and stretch the contracted muscle groups that are especially prone to pain in musicians (back and upper limbs), and a final part of calming and breathing exercises.

At the beginning and at the end of the study, participants of both groups will be asked to complete a Polish version of validated psychological questionnaires: Kenny Music Performance Anxiety Inventory-Revised, Ogińska-Bulik's & Juczyński's Resiliency Assessment Scale (SPP-25), Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians of the Polish Population (MPIIQM-P) and one original questionnaire assessing the stress level before, during and after a performance. All participants will also undergo physical examination. A measurement of the range of motion of trunk flexion in standing (cm) and the algometric measurement of the pain threshold (kg/cm2) of selected back muscles (trapezius muscles, upper and lower and levator scapula) on the right and left sides of the body. Algometric measurements will be made using the Pain Test FPX algometer Algometer (Wagner).

Statistical analysis. The variables will be coded and analyzed using the STATISTICA program. Baseline demographics will be compared between groups (independent t-tests, chi-square tests). Two-way mixed-model analyses of variance (ANOVA) will explore the effect of the exercise program on symptoms and anxiety.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Poland
      • Warsaw, Poland
        • Recruiting
        • Józef Piłsudski University of Physical Education in Warsaw
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • playing on a musical instrument for at least 5 years
  • age 18 to 35
  • consent to participate in the study
  • participation in at least 8 meetings (exercise) within 6 weeks

Exclusion Criteria:

  • current (last 3 months) locomotor injuries (fractures, sprains, dislocations), medical contraindications to exercise, confirmed by a medical opinion
  • neurological and oncological diseases confirmed by a medical diagnosis
  • previous spine surgeries, scoliosis confirmed by radiograph (<10ᵒ Cobb)
  • regular intake of muscle relaxants, painkillers, anti-inflammatory drugs, anti-depressants
  • age under 18 or over 35
  • no consent to participate in the study to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
The participants of the study will take part in exercises (proprietary exercise program), 2 times per week, 45 minutes, for 6 weeks. They will be measured before and after the 6-week exercise program.
Other: Physical Exercises
An original, noninvasive exercise program
No Intervention: Control group
The study participants will not be subjected to any intervention, they will be measured twice, 6 weeks apart. They will be asked to lead their habitual lifestyle.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety level - total
Time Frame: Before starting the study
Kenny Music Performance Anxiety Inventory - Certified Polish translation; the total score in the questionnaire shows the strength of stage fright; the higher the score, the greater the stage fright; from 0 to 240;
Before starting the study
Anxiety level - specific psychological predispositions (SPP)
Time Frame: Change between Baseline and post-treatment, 6 weeks
Kenny Music Performance Anxiety Inventory - Certified Polish translation; the higher the score, the worse the specific psychological predispositions; from 0 to 96;
Change between Baseline and post-treatment, 6 weeks
Pain Interference
Time Frame: Change between Baseline and post-treatment, 6 weeks
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P); from 0 to 50, the higher the score, the greater the pain interference;
Change between Baseline and post-treatment, 6 weeks
Pain Intensity
Time Frame: Change between Baseline and post-treatment, 6 weeks
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P); from 0 to 40, the higher the score, the greater the pain intensity;
Change between Baseline and post-treatment, 6 weeks
Anxiety level - biological predisposition (BP)
Time Frame: Change between Baseline and post-treatment, 6 weeks
Kenny Music Performance Anxiety Inventory - Certified Polish translation; the higher the score, the worse the biological predisposition; from 0 to 30;
Change between Baseline and post-treatment, 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Flexibility level
Time Frame: Change between Baseline and post-treatment, 6 weeks
Trunk flexion assessment in standing in centimeters
Change between Baseline and post-treatment, 6 weeks
Changes in algometric measurements
Time Frame: Change between Baseline and post-treatment, 6 weeks
The algometric measurement concerns the assessment of muscle pressure sensitivity - pain threshold in kg/cm2 made using the Pain Test FPX Algometer (Wagner).
Change between Baseline and post-treatment, 6 weeks
Resilience level
Time Frame: Before starting the study
The Polish Version of the Resilience Scale 25; The higher the score obtained on the scale, the higher it is resilience is presented by the person completing the questionnaire (from 0 to 100; 0-65 - means low resilience, 66-77 - means medium resilience, and 78-100 means high resilience);
Before starting the study
Anxiety level - general psychological predisposition (GPP)
Time Frame: Before starting the study
Kenny Music Performance Anxiety Inventory - Certified Polish translation; the higher the score, the worse the general psychological predisposition; from 0 to 114;
Before starting the study
Anxiety level during last performance
Time Frame: Change between Baseline and post-treatment, 6 weeks
Authors own questionnaire; the higher the score, the greater the stage fright; from 5 to 30;
Change between Baseline and post-treatment, 6 weeks
Assessment of exercises an program
Time Frame: After 6 weeks of exercise program
Authors own questionnaire; the higher the score, the higher the rating of the original exercise program; from16 to 96;
After 6 weeks of exercise program

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Before starting the study
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Before starting the study
Gender
Time Frame: Before starting the study
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Before starting the study
Instrument played
Time Frame: Before starting the study
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Before starting the study
Practice time (years)
Time Frame: Before starting the study
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Before starting the study
Weekly practice time (hours)
Time Frame: Before starting the study
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Before starting the study
Presence of pain
Time Frame: Baseline and after 6 weeks
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Baseline and after 6 weeks
Localisation of pain (number)
Time Frame: Baseline and after 6 weeks
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Baseline and after 6 weeks
Localisation of pain (body area)
Time Frame: Baseline and after 6 weeks
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Baseline and after 6 weeks
Prevalence of pain
Time Frame: Baseline and after 6 weeks
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P)
Baseline and after 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Anna Cygańska

Investigators

  • Principal Investigator: Anna K. Cygańska, Doctor, Józef Piłsudski University of Physical Education in Warsaw

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 13, 2022

Primary Completion (Estimated)

September 28, 2023

Study Completion (Estimated)

December 30, 2023

Study Registration Dates

First Submitted

November 29, 2022

First Submitted That Met QC Criteria

November 29, 2022

First Posted (Actual)

December 7, 2022

Study Record Updates

Last Update Posted (Actual)

June 6, 2023

Last Update Submitted That Met QC Criteria

June 5, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SKE 01-26/2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Physical Exercises

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe